Graffeo, C. S.; Perry, A.; Copeland, W. R.; Giannini, C.; Neff, B. A.; Driscoll, C. L. W.; Link, M. J., Synchronous Tumors of the Cerebellopontine Angle, «WORLD NEUROSURGERY», 2017, 98, pp. 632 - 643 [articolo]
Lassaletta, A.; Zapotocky, M.; Mistry, M.; Ramaswamy, V.; Honnorat, M.; Krishnatry, R.; Stucklin, A. G.; Zhukova, N.; Arnoldo, A.; Ryall, S.; Ling, C.; Mckeown, T.; Loukides, J.; Cruz, O.; De Torres, C.; Ho, C. -Y.; Packer, R. J.; Tatevossian, R.; Qaddoumi, I.; Harreld, J. H.; Dalton, J. D.; Mulcahy-Levy, J.; Foreman, N.; Karajannis, M. A.; Wang, S.; Snuderl, M.; Rao, A. N.; Giannini, C.; Kieran, M.; Ligon, K. L.; Garre, M. L.; Nozza, P.; Mascelli, S.; Raso, A.; Mueller, S.; Nicolaides, T.; Silva, K.; Perbet, R.; Vasiljevic, A.; Conter, C. F.; Frappaz, D.; Leary, S.; Crane, C.; Chan, A.; Ng, H. -K.; Shi, Z. -F.; Mao, Y.; Finch, E.; Eisenstat, D.; Wilson, B.; Carret, A. S.; Hauser, P.; Sumerauer, D.; Krskova, L.; Larouche, V.; Fleming, A.; Zelcer, S.; Jabado, N.; Rutka, J. T.; Dirks, P.; Taylor, M. D.; Chen, S.; Bartels, U.; Huang, A.; Ellison, D. W.; Bouffet, E.; Hawkins, C.; Tabori, U., Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas, «JOURNAL OF CLINICAL ONCOLOGY», 2017, 35, pp. 2934 - 2941 [articolo]
Johnson D.R.; Guerin J.B.; Giannini C.; Morris J.M.; Eckel L.J.; Kaufmann T.J., 2016 updates to the WHO brain tumor classification system: What the radiologist needs to know, «RADIOGRAPHICS», 2017, 37, pp. 2164 - 2180 [articolo]
D. Hughes J.; Retzlaff A.; Sims J.; O'Brien E.; Giannini C.; Huston J.; Van Gompel J.J., Adenoid Cystic Carcinoma Metastatic to the Pituitary: A Case Report and Discussion of Potential Diagnostic Value of Magnetic Resonance Elastography in Pituitary Tumors, «WORLD NEUROSURGERY», 2016, 91, pp. 669 - 669.e14 [articolo]
Yamada S.; Kipp B.R.; Voss J.S.; Giannini C.; Raghunathan A., Combined infiltrating astrocytoma/pleomorphic xanthoastrocytoma harboring IDH1 R132H and BRAF V600E mutations, «THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY», 2016, 40, pp. 279 - 284 [articolo]
Carter J.M.; Howe B.M.; Hawse J.R.; Giannini C.; Spinner R.J.; Fritchie K.J., CTNNB1 mutations and estrogen receptor expression in neuromuscular choristoma and its associated fibromatosis, «THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY», 2016, 40, pp. 1368 - 1374 [articolo]
Flanagan E.P.; Kaufmann T.J.; Krecke K.N.; Aksamit A.J.; Pittock S.J.; Keegan B.M.; Giannini C.; Weinshenker B.G., Discriminating long myelitis of neuromyelitis optica from sarcoidosis, «ANNALS OF NEUROLOGY», 2016, 79, pp. 437 - 447 [articolo]
Graff-Radford, J.; Josephs, K. A.; Parisi, J. E.; Dickson, D. W.; Giannini, C.; Boeve, B. F., Globular glial tauopathy presenting as semantic variant primary progressive aphasia, «JAMA NEUROLOGY», 2016, 73, pp. 123 - 125 [replica/breve intervento]
Salvarani C.; Morris J.M.; Giannini C.; Brown R.D.; Christianson T.; Hunder G.G., Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation, «MEDICINE», 2016, 95, Article number: e3613, pp. 1 - 7 [articolo]Open Access
Vaubel R.A.; Chen S.G.; Raleigh D.R.; Link M.J.; Chicoine M.R.; Barani I.; Jenkins S.M.; Aleff P.A.; Rodriguez F.J.; Burger P.C.; Dahiya S.; Perry A.; Giannini C., Meningiomas with rhabdoid features lacking other histologic features of malignancy: A study of 44 cases and review of the literature, «JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY», 2016, 75, pp. 44 - 52 [articolo]
Nauen D.; Haley L.; Lin M.-T.; Perry A.; Giannini C.; Burger P.C.; Rodriguez F.J., Molecular analysis of pediatric oligodendrogliomas highlights genetic differences with adult counterparts and other pediatric gliomas, «BRAIN PATHOLOGY», 2016, 26, pp. 206 - 214 [articolo]
Bandopadhayay P.; Ramkissoon L.A.; Jain P.; Bergthold G.; Wala J.; Zeid R.; Schumacher S.E.; Urbanski L.; O'Rourke R.; Gibson W.J.; Pelton K.; Ramkissoon S.H.; Han H.J.; Zhu Y.; Choudhari N.; Silva A.; Boucher K.; Henn R.E.; Kang Y.J.; Knoff D.; Paolella B.R.; Gladden-Young A.; Varlet P.; Pages M.; Horowitz P.M.; Federation A.; Malkin H.; Tracy A.A.; Seepo S.; Ducar M.; Van Hummelen P.; Santi M.; Buccoliero A.M.; Scagnet M.; Bowers D.C.; Giannini C.; Puget S.; Hawkins C.; Tabori U.; Klekner A.; Bognar L.; Burger P.C.; Eberhart C.; Rodriguez F.J.; Hill D.A.; Mueller S.; Haas-Kogan D.A.; Phillips J.J.; Santagata S.; Stiles C.D.; Bradner J.E.; Jabado N.; Goren A.; Grill J.; Ligon A.H.; Goumnerova L.; Waanders A.J.; Storm P.B.; Kieran M.W.; Ligon K.L.; Beroukhim R.; Resnick A.C., MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism, «NATURE GENETICS», 2016, 48, pp. 273 - 282 [articolo]
Fritchie K.J.; Jin L.; Rubin B.P.; Burger P.C.; Jenkins S.M.; Barthelmeb S.; Moskalev E.A.; Haller F.; Oliveira A.M.; Giannini C., NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor, «JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY», 2016, 75, pp. 263 - 271 [articolo]
Hasselblatt M.; Thomas C.; Hovestadt V.; Schrimpf D.; Johann P.; Bens S.; Oyen F.; Peetz-Dienhart S.; Crede Y.; Wefers A.; Vogel H.; Riemenschneider M.J.; Antonelli M.; Giangaspero F.; Bernardo M.C.; Giannini C.; Ud Din N.; Perry A.; Keyvani K.; van Landeghem F.; Sumerauer D.; Hauser P.; Capper D.; Korshunov A.; Jones D.T.W.; Pfister S.M.; Schneppenheim R.; Siebert R.; Fruhwald M.C.; Kool M., Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis, «ACTA NEUROPATHOLOGICA», 2016, 132, pp. 149 - 151 [articolo]
Thompson E.M.; Hielscher T.; Bouffet E.; Remke M.; Luu B.; Gururangan S.; McLendon R.E.; Bigner D.D.; Lipp E.S.; Perreault S.; Cho Y.-J.; Grant G.; Kim S.-K.; Lee J.Y.; Rao A.A.N.; Giannini C.; Li K.K.W.; Ng H.-K.; Yao Y.; Kumabe T.; Tominaga T.; Grajkowska W.A.; Perek-Polnik M.; Low D.C.Y.; Seow W.T.; Chang K.T.E.; Mora J.; Pollack I.F.; Hamilton R.L.; Leary S.; Moore A.S.; Ingram W.J.; Hallahan A.R.; Jouvet A.; Fevre-Montange M.; Vasiljevic A.; Faure-Conter C.; Shofuda T.; Kagawa N.; Hashimoto N.; Jabado N.; Weil A.G.; Gayden T.; Wataya T.; Shalaby T.; Grotzer M.; Zitterbart K.; Sterba J.; Kren L.; Hortobagyi T.; Klekner A.; Laszlo B.; Pocza T.; Hauser P.; Schuller U.; Jung S.; Jang W.-Y.; French P.J.; Kros J.M.; van Veelen M.-L.C.; Massimi L.; Leonard J.R.; Rubin J.B.; Vibhakar R.; Chambless L.B.; Cooper M.K.; Thompson R.C.; Faria C.C.; Carvalho A.; Nunes S.; Pimentel J.; Fan X.; Muraszko K.M.; Lopez-Aguilar E.; Lyden D.; Garzia L.; Shih D.J.H.; Kijima N.; Schneider C.; Adamski J.;, Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis, «THE LANCET ONCOLOGY», 2016, 17, pp. 484 - 495 [articolo]
